The expression of CD133/PROM1, one of the CSC markers reported in pancreatic cancer [18], was confirmed and particularly well expressed in PDOs (Fig. 1c, d, and Supplementary Fig. 1b). The gene discussed is PROM1; the disease is pancreatic neoplasm.